Transporting Cell Therapies Without Refrigeration

The US Advanced Research Projects Agency for Health, ARPA-H, has announced contracts with three development teams and an independent testing organization under BoSS, a program aiming to preserve cell-based products at room temperature. The planned investment is up to $87 million over four years. Teams from companies, universities and other organizations will work toward milestones defined for each stage of development. Official announcement ↗

The aim is not to improve insulated shipping containers. The teams are seeking ways to suppress cellular metabolism and combine protective materials, drying techniques and other approaches so that cells can recover the functions they need after room-temperature storage. The work spans preservation agents, cell-processing equipment and manufacturing processes. Program overview ↗

ATCC, which will conduct independent testing, preserves and supplies cells and microorganisms and also offers services such as cell authentication and contamination testing. For this program, it will supply cells for shared evaluations and assess survival, function and other properties after storage, independently of the development teams. ATCC services ↗

What stands out is where the research funding is going: not toward a new therapeutic target, but toward storage and transport constraints shared by multiple cell therapies. Even without changing the treatment itself, a technology that makes it easier to handle can give pharmaceutical companies and contract manufacturers a reason to adopt it.